BTOG 2023 | Using real-world data to optimize patient pathways in lung cancer

Apurna Jegannathen, MD, Royal Stoke University Hospital, Stoke-on-Trent, UK, discusses the importance of real-world data in the treatment of lung cancer. Adjuvant durvalumab has shown success concurrently with radiotherapy as part of the PACIFIC trial (NCT02125461). Following this, a 5-year outcome was conducted to study efficacy and toxicity. Progression-free survival was double that found in the PACIFIC trial, highlighting the difference between clinical trials and real-world data. This provides options and confidence to optimize patient pathways and treatment, which supports the collection of real-world data to form an evidence-based database. This interview took place at the British Thoracic Oncology Group (BTOG) Annual Conference 2023 in Belfast, UK.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.